P Bruggmann

Summary

Country: Switzerland

Publications

  1. pmc An integrated model of care to counter high incidence of HIV and sexually transmitted diseases in men who have sex with men - initial analysis of service utilizers in Zurich
    David L B Schwappach
    Research Institute for Public Health and Addiction, Zurich, Switzerland
    BMC Public Health 8:180. 2008
  2. doi request reprint Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients
    P Bruggmann
    ARUD Zurich, Association for Risk Reduction in the Use of Drugs, Zurich, Switzerland
    J Viral Hepat 15:747-52. 2008
  3. doi request reprint Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study
    P Bruggmann
    ARUD Zurich, Konradstr 32, 8005 Zurich, Switzerland
    Drug Alcohol Depend 110:167-71. 2010
  4. ncbi request reprint Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital
    K Fritsch
    Kantonsspital Munsterlingen, CH 8596 Münsterlingen, Switzerland
    Swiss Med Wkly 135:116-21. 2005

Collaborators

  • F Negro
  • B Helbling
  • David L B Schwappach
  • K Fritsch
  • R Thurnheer
  • M Krause
  • F Wick
  • A Klarer
  • M L Jacot

Detail Information

Publications4

  1. pmc An integrated model of care to counter high incidence of HIV and sexually transmitted diseases in men who have sex with men - initial analysis of service utilizers in Zurich
    David L B Schwappach
    Research Institute for Public Health and Addiction, Zurich, Switzerland
    BMC Public Health 8:180. 2008
    ..We describe first experiences with the new service and report the characteristics of the population that utilized it...
  2. doi request reprint Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients
    P Bruggmann
    ARUD Zurich, Association for Risk Reduction in the Use of Drugs, Zurich, Switzerland
    J Viral Hepat 15:747-52. 2008
    ..In conclusion, our study shows no relevant direct influence of IV drugs on the efficacy of anti-HCV therapy among adherent patients...
  3. doi request reprint Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study
    P Bruggmann
    ARUD Zurich, Konradstr 32, 8005 Zurich, Switzerland
    Drug Alcohol Depend 110:167-71. 2010
    ..The aim of our study was to investigate the influence of ongoing alcohol intake on sustained viral response (SVR) rates in adherent patients receiving hepatitis C treatment...
  4. ncbi request reprint Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital
    K Fritsch
    Kantonsspital Munsterlingen, CH 8596 Münsterlingen, Switzerland
    Swiss Med Wkly 135:116-21. 2005
    ..We aimed at assessing adherence to the proposed guidelines by the physicians in charge for all patients referred to our hospital for acute exacerbations of COPD over a one year period...